Allergen Research Corp.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Allergen Research Corp. - overview
Established
2011
Location
Menlo Park, CA, US
Primary Industry
Pharmaceuticals
About
Allergen Research Corp. specializes in providing a premium domain name for sale, aimed at enhancing the visibility and credibility of businesses within allergen research and health sectors. Founded in 2011, Allergen Research Corp. operates from Menlo Park, US, focusing on offering its domain name to entities involved in allergen research.
The company has raised a total of USD 80 mn in its Series B funding round on March 12, 2015, having completed 2 deals to date. AllergenResearch. com primarily offers a domain name for sale, serving as a digital asset for businesses and individuals in the allergen research sector. This domain enhances online visibility for companies engaged in allergen-related research, product development, and education, targeting a diverse clientele including researchers and healthcare providers globally.
The revenue model for AllergenResearch. com is based on the sale of its domain name, priced at USD 8,195 or through a monthly payment plan of USD 682. 92 for 12 months, facilitating transactions with both individual consumers and businesses. Allergen Research Corp.
aims to leverage its recent Series B funding of USD 80 mn to expand its market presence. Plans include targeting new geographic regions for potential buyers looking to enhance their online presence in allergen research. Specific new products or services are not outlined at this time.
Current Investors
Longitude Capital
Primary Industry
Pharmaceuticals
Sub Industries
Epidemiology, Pharmaceutical Research & Development
Website
www.allergenresearch.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Allergen Research Corp. - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 |
|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - |
| EBITDA (USD) | (35,558,000) | (80,074,000) | - | - | - |
| Operating Income (USD) | (35,997,000) | (81,527,000) | - | - | - |
| Operating Margin | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - |
| NET Income (USD) | (35,816,000) | (80,824,000) | - | - | - |
| % Net Margin | - | - | - | - | - |
Allergen Research Corp. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.